Literature DB >> 12229267

Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer.

Silvia Kocova el-Arini1, Sophie-Dorothée Clas.   

Abstract

The in vitro disintegration behavior of fast dissolving systems manufactured by the main commercialized technologies was studied using the texture analyzer (TA) instrument. Quantitative parameters were employed to characterize the effect of the major test variables on the disintegration profiles. The average disintegration profiles of the products were compared using the test conditions that minimized these effects and at the same time mimicked the in vivo situation in the patient's mouth. The differences in the disintegration mechanisms of the fast dissolving systems were reflected in the shape of their disintegration profiles and in the parameters derived from the profiles. The differences were explained in relation to the technology and/or formulation characteristics involved in the manufacture of each product. The in vitro disintegration times obtained under the simulated in vivo conditions were correlated with the reported in vivo disintegration times.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12229267     DOI: 10.1081/pdt-120005732

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  9 in total

1.  Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Authors:  Mutasem M Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2006-04-28       Impact factor: 3.246

2.  FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.

Authors:  Cynthia K Brown; Horst Dieter Friedel; Amy R Barker; Lucinda F Buhse; Susanne Keitel; Todd L Cecil; Johannes Kraemer; J Michael Morris; Christos Reppas; Mary P Stickelmeyer; Chikako Yomota; Vinod P Shah
Journal:  AAPS PharmSciTech       Date:  2011-06-18       Impact factor: 3.246

3.  Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets.

Authors:  Tanja Stirnimann; Nicola Di Maiuta; Daniel E Gerard; Rainer Alles; Jörg Huwyler; Maxim Puchkov
Journal:  Pharm Res       Date:  2013-04-19       Impact factor: 4.200

4.  Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.

Authors:  Jonas Buck; Jörg Huwyler; Peter Kühl; Angela Dischinger
Journal:  Pharm Res       Date:  2016-06-01       Impact factor: 4.200

5.  Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets.

Authors:  Osamah Malallah; Zara Rashid; Chee Lok Li; Abdulmalik Alqurshi; Mohamed A Alhanan; Ben Forbes; Paul G Royall
Journal:  AAPS PharmSciTech       Date:  2021-08-16       Impact factor: 3.246

6.  Physicomechanical characterization and optimization of EDTA-mPEG and Avicel®-EDTA-mPEG in situ melt dispersion mini-pellets.

Authors:  Angus R Hibbins; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-06-04       Impact factor: 3.246

7.  In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride.

Authors:  Vinay Pandit; Roopa S Pai; Kusum Devi; Sarasija Suresh
Journal:  J Adv Pharm Technol Res       Date:  2012-07

8.  Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.

Authors:  Jasdip S Koner; Ali R Rajabi-Siahboomi; Shahrzad Missaghi; Daniel Kirby; Yvonne Perrie; Jiteen Ahmed; Afzal R Mohammed
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

Review 9.  Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.

Authors:  Mohammadali Poursharifi Ghourichay; Seyed Hossein Kiaie; Ali Nokhodchi; Yousef Javadzadeh
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.